For the year ending 2025-12-31, APTN has $619,159 in assets. $2,108,555 in debts. $459,174 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 459,174 | |||
| Prepaid expenses and other current assets | 159,985 | |||
| Total current assets | 619,159 | |||
| Total assets | 619,159 | |||
| Accounts payable- trade | 1,512,090 | |||
| Accrued expenses | 596,465 | |||
| Total current liabilities | 2,108,555 | |||
| Total liabilities | 2,108,555 | |||
| Common stock, 0.0001 par value, 50,000,000 shares authorized, 8,655,829 and 3,249,999 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 866 | |||
| Additional paid-in capital | 7,801,539 | |||
| Accumulated deficit | -9,291,801 | |||
| Total stockholders deficit | -1,489,396 | |||
| Total liabilities and stockholders deficit | 619,159 | |||
ADAPTIN BIO, INC. (APTN)
ADAPTIN BIO, INC. (APTN)